Related Experiment Videos
Optimized large-scale production of high titer lentivirus vector pseudotypes
Miguel Sena-Esteves1, Jessica C Tebbets, Sabine Steffens
1Department of Surgery, The Children's Hospital of Philadelphia, Abramson Research Center, 3615 Civic Center Blvd., Philadelphia, PA 19104, USA. msesteves@partners.org
Journal of Virological Methods
|November 16, 2004
Summary
This study optimized lentivirus vector production for eight pseudotypes, achieving high titers exceeding 1 x 10^9 tu/mL. Key factors included envelope gene selection and concentration methods for efficient large-scale lentivirus vector manufacturing.
Area of Science:
- Molecular Biology
- Biotechnology
- Virology
Background:
- Lentivirus vectors are crucial for gene therapy and research.
- Efficient large-scale production of high-titer lentivirus vector stocks is essential.
- Optimizing pseudotype choice and production conditions is key to maximizing vector yield.
Purpose of the Study:
- To develop an efficient transient transfection method for large-scale lentivirus vector production.
- To evaluate eight different lentivirus vector pseudotypes for high-titer stock generation.
- To optimize production parameters including envelope gene expression, sodium butyrate treatment, serum-free media, and concentration methods.
Main Methods:
- Cloning of eight different envelope genes (VSV-G, Mokola, Rabies, MLV-Ampho, MLV-10A1, LCMV-WE, LCMV-Arm53b) into phCMV expression plasmids.
- Transient transfection for lentivirus vector production.
- Evaluation of sodium butyrate treatment, serum-free media, and concentration techniques (ultracentrifugation vs. ultrafiltration).
Main Results:
- Newly constructed envelope expression plasmids significantly increased lentivirus vector titers compared to original plasmids for Rabies, MLV-10A1, and MLV-Ampho.
- Sodium butyrate treatment enhanced titers for some pseudotypes but negatively impacted LCMV-derived ones.
- Serum-free media resulted in only slightly lower titers; ultracentrifugation yielded higher titers than ultrafiltration for most pseudotypes.
- Optimized conditions produced lentivirus vector stocks with titers >1 x 10^9 tu/mL for most pseudotypes and >1 x 10^10 tu/mL for VSV-G.
Conclusions:
- An efficient transient transfection method for large-scale lentivirus vector production was successfully developed.
- Pseudotype selection and optimization of production parameters are critical for achieving high-titer lentivirus vector stocks.
- The optimized methods enable the generation of high-titer lentivirus vector stocks suitable for various gene therapy and research applications.